Abstract
Zuclopenthixol acetate, 5%, in ViscoleosR was administered IM to 19 acutely disturbed, psychotic patients in doses of 50–150 mg. Fifteen patients received one injection, whereas four of the patients had two or three injections, usually with intervals of 3 days. The zuclopenthixol concentrations in serum were measured in series of samples taken from each patient during a 3-day period following the injection. In patients given identical doses serum concentrations of about the same order were obtained. Significant and good correlations were found between dose and maximal serum concentration and between dose and area under the serum concentration curve. The average serum concentration curve obtained when adjusting the data to a 100 mg dose has a maximum of 41 ng/ml after about 36 h, decreasing to 15 ng/ml after 72 h.
A dose of 50–150 mg zuclopenthixol acetate in Viscoleo® appeared to be sufficient for controlling the symptoms for most acutely disturbed, psychotic patients. The frequency of side effects, including extrapyramidal reactions, was low and the adverse reactions mostly mild, indicating that the risks for severe complications generally might be minimal. With a rapid onset of action, few and mild side effects, good tolerability at the injection site, and a duration of effect of 2–3 days, zuclopenthixol acetate in Viscoleo® appears to offer advantages compared to conventional neuroleptic treatment in patients in whom an acute, calming effect is desired.
Similar content being viewed by others
References
Aaes-Jørgensen T (1980) Specific high performance liquid chromatographic method for estimation of the cis(Z)- and trans(E)-isomers of clopenthixol and a N-dealkyl metabolite. J Chromatogr 183:239–245
Aaes-Jørgensen T, Gravem A, Jørgensen A (1981) Serum levels of the isomers of clopenthixol in patients given cis(Z)-clopenthixol or cis(Z)/trans(E)-clopenthixol. Acta Psychiatr Scand 64, suppl. 294:70–77
Aaes-Jørgensen T, Fredricson Overø K, Bøgesø KP, Jørgensen A (1977) Pharmacokinetic studies on clopenthixol decanoate; a comparison with clopenthixol in dogs and rats. Acta Pharmacol Toxicol 41:103–120
Aaes-Jørgensen T, Kirk L, Petersen E, Danneskiold-Samsøe P, Jørgensen A (1983) Serum concentrations of the isomers of clopenthixol and a metabolite in patients given cis(Z)-clopenthixol decanoate in Viscoleo. Psychopharmacology 81:68–72
Bjørndal F, Aaes-Jørgensen T (1982) Manibehandling med cis(Z)-clopenthixol (Cisordinol®, Clopixol®). Nord Psykiatr Tidskr 36:321–324
Bjørndal F, Aaes-Jørgensen T (1984) Serum koncentrationer ved akutte paranoide psykoser behandlet med cis(Z)-clopenthixol. Nord Psykiatr Tidsskr 38:229–233
Bollini P, Amdreani A, Colombo F, Bellantuono C, Beretta P, Arduini A, Galli T, Togni G (1984) High-dose neuroleptics: Uncontrolled clinical practice confirms controlled clinical trials. Br J Psychiatry 144:25–27
Bolvig Hansen L, Elley J, Rosted Christensen T, Larsen N-E, Næstoft J, Hvidberg EF (1979) Plasma levels of perphenazine and its major metabolites during simultaneous treatment with anticholinergic drugs. Br J Clin Pharmacol 7:75–80
Donlon PT, Hopkin JT, Tupin JP, Wicks JJ, Wahba M, Meadow A (1980) Haloperidol for acute schizophrenic patients. Arch Gen Psychiatry 37:691–695
Fredricson Overø K (1980) A specific fluorimetric method for assay of drug levels in serum of patients treated with clopenthixol decanoate injections. Acta Psychiatr Scand 61, suppl 279:92–103
Guy W (1976) ECDEU assessment manual for psychopharmacology. DHEW publication No (ADM) 76–338. National Institute of Mental Health, Rockville, Maryland, USA
Jørgensen A, Fredricson Overø K (1980) Clopenthixol and flupentixol depot preparations in outpatient schizophrenics. III. Serum levels. Acta Psychiatr Scand 61, suppl. 279:41–54
Lingjærde O (1976) Psykofarmaka, Tanum-Norli A/S, Oslo
Neborsky R, Janowsky D, Munson E, Depry D (1981) Rapid treatment of acute psychotic symptoms with high and low dose haloperidol. Arch Gen Psychiatry 38:195–199
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Amdisen, A., Aaes-Jørgensen, T., Thomsen, N.J. et al. Serum concentrations and clinical effect of zuclopenthixol in acutely disturbed, psychotic patients treated with zuclopenthixol acetate in Viscoleo® . Psychopharmacology 90, 412–416 (1986). https://doi.org/10.1007/BF00179201
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00179201